BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15901156)

  • 1. Synthetic studies on the bryostatins: preparation of a truncated BC-ring intermediate by pyran annulation.
    Keck GE; Truong AP
    Org Lett; 2005 May; 7(11):2149-52. PubMed ID: 15901156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic studies on the bryostatins: synthetic routes to analogues containing the tricyclic macrolactone core.
    Keck GE; Truong AP
    Org Lett; 2005 May; 7(11):2153-6. PubMed ID: 15901157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total syntheses of bryostatins: synthesis of two ring-expanded bryostatin analogues and the development of a new-generation strategy to access the C7-C27 fragment.
    Trost BM; Yang H; Dong G
    Chemistry; 2011 Aug; 17(35):9789-805. PubMed ID: 21780195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convergent assembly of highly potent analogues of bryostatin 1 via pyran annulation: bryostatin look-alikes that mimic phorbol ester function.
    Keck GE; Kraft MB; Truong AP; Li W; Sanchez CC; Kedei N; Lewin NE; Blumberg PM
    J Am Chem Soc; 2008 May; 130(21):6660-1. PubMed ID: 18452293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioselective reductive coupling of alkynes and alpha-keto aldehydes via rhodium-catalyzed hydrogenation: an approach to bryostatin substructures.
    Cho CW; Krische MJ
    Org Lett; 2006 Mar; 8(5):891-4. PubMed ID: 16494467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of the bryostatin 1 northern hemisphere (C1-C16) via desymmetrization by ketalization/ring-closing metathesis.
    Voight EA; Seradj H; Roethle PA; Burke SD
    Org Lett; 2004 Oct; 6(22):4045-8. PubMed ID: 15496095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic studies toward the bryostatins: a substrate-controlled approach to the A-ring.
    Keck GE; Welch DS; Vivian PK
    Org Lett; 2006 Aug; 8(17):3667-70. PubMed ID: 16898787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantio- and diastereoselective additions to aldehydes using the bifunctional reagent 2-(chloromethyl)-3-(tributylstannyl)propene: application to a synthesis of the C16-C27 segment of bryostatin 1.
    Keck GE; Yu T; McLaws MD
    J Org Chem; 2005 Apr; 70(7):2543-50. PubMed ID: 15787541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioselective synthesis of pladienolide B and truncated analogues as new anticancer agents.
    Kumar VP; Chandrasekhar S
    Org Lett; 2013 Jul; 15(14):3610-3. PubMed ID: 23822896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioselective formal total synthesis of the antitumor macrolide bryostatin 7.
    Manaviazar S; Frigerio M; Bhatia GS; Hummersone MG; Aliev AE; Hale KJ
    Org Lett; 2006 Sep; 8(20):4477-80. PubMed ID: 16986929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new synthetic approach to the C ring of known as well as novel bryostatin analogues.
    Wender PA; Koehler MF; Sendzik M
    Org Lett; 2003 Nov; 5(24):4549-52. PubMed ID: 14627380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective synthesis of both tetrahydropyran rings of the antitumor macrolide, (-)-lasonolide A.
    Ghosh AK; Ren GB
    J Org Chem; 2012 Mar; 77(5):2559-65. PubMed ID: 22324913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective synthesis of the macrolactone core of (+)-neopeltolide.
    Raghavan S; Samanta PK
    Org Lett; 2012 May; 14(9):2346-9. PubMed ID: 22515229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of olefin geometry in the bryostatin B-ring through exploitation of a C(2)-symmetry breaking tactic and a Smith-Tietze coupling reaction.
    Hale KJ; Hummersone MG; Bhatia GS
    Org Lett; 2000 Jul; 2(15):2189-92. PubMed ID: 10930240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total synthesis of bryostatin 16 using a Pd-catalyzed diyne coupling as macrocyclization method and synthesis of C20-epi-bryostatin 7 as a potent anticancer agent.
    Trost BM; Dong G
    J Am Chem Soc; 2010 Nov; 132(46):16403-16. PubMed ID: 21043491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis of potent antitumor agent (-)-lasonolide A: a cycloaddition-based strategy.
    Ghosh AK; Gong G
    Chem Asian J; 2008 Oct; 3(10):1811-23. PubMed ID: 18712746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a tunable site in bryostatin analogs: C20 Bryologs through late stage diversification.
    Wender PA; Baryza JL
    Org Lett; 2005 Mar; 7(6):1177-80. PubMed ID: 15760168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total synthesis and initial biological evaluation of new B-ring-modified bryostatin analogs.
    Wender PA; Horan JC; Verma VA
    Org Lett; 2006 Nov; 8(23):5299-302. PubMed ID: 17078702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atom-economic and stereoselective syntheses of the ring a and B subunits of the bryostatins.
    Trost BM; Yang H; Brindle CS; Dong G
    Chemistry; 2011 Aug; 17(35):9777-88. PubMed ID: 21774000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective, Ag-Catalyzed Cyclizations To Access Polysubstituted Pyran Ring Systems: Synthesis of C1-C12 Subunit of Madeirolide A.
    Watanabe K; Li J; Veerasamy N; Ghosh A; Carter RG
    Org Lett; 2016 Apr; 18(8):1744-7. PubMed ID: 27031993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.